GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation to the Analyst/ Investors23-01-2024
23-01-2024
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release to the Analysts/Investors23-01-2024
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Change in Directorate
Outcome of the Board Meeting dated January 23,202423-01-2024
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Approval Of The Unaudited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On December 31, 2023
Approval of the unaudited financial results (Standalone & Consolidated) for the third quarter and nine months ended on December 31, 202323-01-2024
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call for Q3 of FY24.11-01-2024
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results For The Third Quarter And Nine-Months Ended On December 31, 2023
GRANULES INDIA LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 ,inter alia, to consider and approve The un-audited Financial Results for the third quarter and nine months ended on December 31, 202310-01-2024
GRANULES INDIA LTD.-$ - 532482 - Closure of Trading Window
Intimation of Trading Window Closure for declaration of unaudited financial results for the nine months & quarter ending on December 31, 202327-12-2023
GRANULES INDIA LTD.-$ - 532482 - Update On The US FDA Audit At GPI Facility
Update on the US FDA audit at GPI facility16-12-2023
Granules India gets USFDA nod for generic pantoprazole sodium tablets
The approval by the US Food Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for pantoprazole sodium delayed-release tablets of strengths 20 mg and 40 mg, Granules India said in a regulatory filing.13-12-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited received ANDA approval for Pantoprazole Sodium Delayed- Release Tablets13-12-2023